Company profile
Supernus Pharmaceuticals, Inc. Insider Trading
SUPNEvery SEC Form 4 insider trading filing for Supernus Pharmaceuticals, Inc. (SUPN) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001356576
- Filings
- 194
- Insiders
- 13
- Last filing
- 2026-08-12
Activity summary
No insider transactions in the last 30 days. The most recent was on August 12, 2026, when Timothy C Dec bought 1,250 shares. 194 filings from 13 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Supernus Pharmaceuticals, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $15.7M.
90 day insight
Over the last 90 days, Supernus Pharmaceuticals, Inc. insiders bought $0 (15 transactions) and sold $725K (5 transactions).
- Most active insider: Jack A. Khattar with 4 transactions totaling $589K.
- Largest single sale: $589K by Jack A. Khattar on Aug 12, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Timothy C Dec | SUPN | Option Exercise | 1,250 | — | — |
| Aug 12, 2026 | Timothy C Dec | SUPN | Tax Withholding | 604 | $46.57 | $28K |
| Aug 12, 2026 | Timothy C Dec | SUPN | Option Exercise | 1,250 | — | — |
| Aug 12, 2026 | Jonathan Rubin | SUPN | Option Exercise | 750 | — | — |
| Aug 12, 2026 | Jonathan Rubin | SUPN | Tax Withholding | 363 | $46.57 | $17K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=SUPN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Supernus Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →